Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar V Parikh

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Journal of Psychiatry & Neuroscience : JPN|March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocolsGlenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
The Journal of Clinical Psychiatry|August 28, 2025
Artificial Intelligence in Depression-Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Deep-Learning-Enabled Clinical Decision Support System for Personalized Depression Treatment Selection and ManagementDavid Benrimoh, Kate Whitmore, Maud Richard, et al.
Nature Communications|May 23, 2017
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genesJuan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 7, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultesRaymond W Lam, Sidney H Kennedy, Camelia Adams, et al.
Journal of Psychiatric Research|July 13, 2026
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorderMichael Van Ameringen, Naomi A Fineberg, Arun Ravindran, et al.
The Australian and New Zealand Journal of Psychiatry|November 1, 2018
Revising <i>Diagnostic and Statistical Manual of Mental Disorders</i>, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC projectGordon Parker, Gabriela Tavella, Glenda Macqueen, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Journal of Psychiatry & Neuroscience : JPN|March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocolsGlenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
The Journal of Clinical Psychiatry|August 28, 2025
Artificial Intelligence in Depression-Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Deep-Learning-Enabled Clinical Decision Support System for Personalized Depression Treatment Selection and ManagementDavid Benrimoh, Kate Whitmore, Maud Richard, et al.
Nature Communications|May 23, 2017
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genesJuan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 7, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultesRaymond W Lam, Sidney H Kennedy, Camelia Adams, et al.
Journal of Psychiatric Research|July 13, 2026
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorderMichael Van Ameringen, Naomi A Fineberg, Arun Ravindran, et al.
The Australian and New Zealand Journal of Psychiatry|November 1, 2018
Revising <i>Diagnostic and Statistical Manual of Mental Disorders</i>, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC projectGordon Parker, Gabriela Tavella, Glenda Macqueen, et al.
Pageof 19